Recruiting CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors NCT07181720 Conditions Adenocarcinoma, Adnexal Diseases, Anaplastic Thyroid Carcinomas, +43 more Locations The 901 Hospital of Joint Logistics Support Force of People Liberation Army — Hefei, Anhui, China View Trial Details
Active, Not Recruiting IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers NCT06790706 Conditions Adenocarcinoma, Anaplastic Thyroid Carcinomas, Carcinoid Tumor, +27 more Locations Institut de Cancerologie de l'Ouest , medical oncology department — Angers, France Institut Bergonié, medical oncology department — Bordeaux, France Hospices Civils de Lyon, Thoracic Oncology Department, Louis Pradel Hospital — Bron, France Centre Hospitalier Universitaire de Lille, medical oncology department — Lille, France View all 15 locations View more locations Show fewer locations Loading locations... View Trial Details
